 Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a U.S. specialty pharmaceutical company, announces a new publication in Drugs - Real World Outcomes1, detailing the positive clinical outcomes with Vibativ in treating patients with bacteremia or endocarditis. 